The top 15 canonical pathways identified by IPA included previously identified and well-known molecules associated with leiomyoma including IGF1 and prolactin and also included previously undisclosed signaling pathways including axonal signaling, stathmin1, glioma signaling and Hepatocyte Growth Factor (Table 2). This evidence concerns the gene PRL and central nervous system cancer.